conventional medicine
PreclinicalSmall molecule
conventional medicine is one of 9 small molecule programs targeting Lumbar Disc Herniation. It is currently in Preclinical.
2
Indications
2
Total Trials
0
Active Trials
8
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
5 competitors in Cerebellar Ataxia
#DrugCompanyPhaseTrials
1Rilutek
AAzurity Pharmaceuticals
Phase 3
Fampridine
BiogenPhase 3
Ampyra
MMerz North America, Inc.
Preclinical
Stemchymal
SSteminent Biotherapeutics Inc.
Phase 2
conventional medicine
JJaseng Medical Foundation
Preclinical
BHV-4157
BBiohaven Therapeutics Ltd.
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Lumbar Disc Herniation1 trial
Cerebellar Ataxia1 trial
Could Tai-chi Help Maintain Balance of Spinocerebellar Ataxia Patients
Completed·—·N/A·NCT03687190·21 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for conventional medicine. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- JJaseng Medical Foundation